Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 15.55
+0.70 (4.71%)
Jan 22, 2026, 1:53 PM CST
Vectorite Biomedical Company Description
Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally.
It offers cell preparation product manufacturing; and collection, processing, and storage management of immune cells.
The company’s cell preparation products are used in the field of infectious diseases and inflammation, cancer, and tumor diseases.
Vectorite Biomedical Inc. was founded in 1993 and is based in New Taipei City, Taiwan.
Vectorite Biomedical Inc.
| Country | Taiwan |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Kechang Ou |
Contact Details
Address: No. 97, Xintai 5th Road New Taipei City, 22175 Taiwan | |
| Phone | 886 2 2697 1100 |
| Website | vectorite.com.tw |
Stock Details
| Ticker Symbol | 4170 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004170006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Kechang Ou | General Manager |